ENTITY
CanSino Biologics

CanSino Biologics (6185 HK)

186
Analysis
Health CareChina
CanSino Biologics Inc. develops and manufactures biological vaccine products. The Company discovers quadrivalence meningococcal conjugate, pneumococcal polysaccharide, and adenovirus vector-based tuberculosis vaccines for human use. CanSino Biologics serves customers worldwide.
more
Presentation Icon
No presentations found
We’ll display presentations we find for CanSino Biologics here
x